Jerome B. Zeldis - Apr 5, 2022 Form 4 Insider Report for NexImmune, Inc. (NEXI)

Role
Executive VP of Research & Dev
Signature
/s/ Ilse Johnson, Attorney-in-fact
Stock symbol
NEXI
Transactions as of
Apr 5, 2022
Transactions value $
$0
Form type
4
Date filed
4/7/2022, 07:12 PM
Previous filing
Mar 28, 2022
Next filing
Nov 21, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NEXI Stock Option (Right to Buy) Award $0 +80.1K $0.00 80.1K Apr 5, 2022 Common Stock 80.1K $4.22 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of this option shall vest and become exercisable on April 5, 2023, with the remainder vesting in 36 equal monthly installments thereafter, subject to Mr. Zeldis's continued service to the corporation on each vesting date.